DABRAFENIB vs DACLATASVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABRAFENIB vs DACLATASVIR: Safety Overview
| Metric | DABRAFENIB | DACLATASVIR |
|---|---|---|
| Total FAERS Reports | 19,305 | 5,602 |
| Deaths Reported | 4,165 | 581 |
| Death Rate | 21.6% | 10.4% |
| Hospitalizations | 5,325 | 1,637 |
| Average Patient Age | 58.3 yrs | 58.1 yrs |
| % Female Patients | 48.0% | 39.7% |
| FDA Approval Date | Mar 16, 2023 | Apr 13, 2016 |
| Manufacturer | Novartis Pharmaceuticals Corporation | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Discontinued |